Many frontotemporal dementia with parkinsonism-17 (FTDP-17) exonic mutations were shown to accelerate tau aggregation in vitro and their overexpression in transgenic animals is currently used to generate models that develop tau aggregates with aging. This evidence concerns the gene MAPT and semantic dementia.